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Effects of urine acidification on plasma and urine 
phencyclidine levels in overdosage 
A gas chromatography-mass Jragmentography-electron impact (GC-MS-EI) assay of 
phencyclidine (PCP) was adapted for human plasma and urine. This assay is specific for 
PCP and very sensitive (approximately I ng/ml). Patients with the putative diagnosis of 
PCP overdosage were studied to correlate plasma and urinary levels with clinical state. 
Urinary PCP levels were enhanced in an acid urine, which suggests that acidification of 
the urine is an adjunct in the therapy of PCP overdosage. 
Edward F. Domino, M.S., M.D., and Ann E. Wilson, M.S. 
Ann Arbor and Detroit, Mich. 
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Phencyclidine (PCP, hog, angel dust, crystal 
THC, peace pill) is currently an important drug 
of abuse. 6, 7, 10-12 Chen and associates3 first 
described its pharmacologic properties and sug-
gested its use as a general anesthetic in man. It 
was subsequently dropped from further clinical 
trials when a large percentage of patients 
showed prolonged emergence delirium. The 
drug produces an unusual psychosis in normal 
people which is a useful "model" of schizo-
phrenia. 4, 5, 9 Currently, its only therapeutic use 
is as an anesthetic in veterinary medicine. Its 
illicit use in the drug subculture is widespread, 
partly due to the ease of its synthesis and its 
reinforcing properties. The determination and 
identification of PCP in biologic fluids and tis-
sues is of obvious interest. With the availabil-
ity of gas chromatography-mass spectrometry 
(GC-MS) it is now possible to obtain positive 
and quantitative identification of this drug. We 
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have reported a GC-MS electron impact (EI) 
assay for measuring PCP plasma pharmacoki-
netics in the dog and monkey. 13 
The purpose of this paper is to report on the 
PCP levels in human plasma and urine during 
states of intoxication, We also present suggest-
ive data on acidification of the urine as a 
possible means of enhancing PCP urinary 
excretion. 
Methods 
Hospitalized patients reported to be intoxi-
cated with PCP were the subjects of this study. 
They were referred to us for positive identifica-
tion of PCP as well as for suggestions on ther-
apy. Whole blood was collected in heparinized 
tubes and spun at 1,000 g for 15 min, and the 
plasma was removed for PCP extraction. Urine 
was collected in standard urine containers. The 
color and pH were noted at the time of collec-
tion, if possible. Samples were frozen at -200 
C until they could be extracted. Usually 1 to 2 
ml of plasma was drawn for analysis. The vol-
ume of urine varied from 1 to 10 ml, depending 
upon availability and degree of intoxication. 
The most practical way was to assay a few ran-
dom samples before extracting all of them, 
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Fig. 1. Total ion chromatograms and mass spectra of phencyclidine and d5-phencyclidine in human 
urine. Note similar retention times of PCP and d5-PCP. Note that m/e 91 and 200 for PCP and m/e 
96 and 205 for d5-PCP are the major ions. A small molecular ion M+ is seen for each. Specific 
retention times vary depending upon density of column packing, flow, etc. 
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Fig. 2. Mass fragmentogram of an extracted urine in 
a case of PCP overdosage. The ions m/ e 91 , 200 and 
96, 205 were monitored for PCP and d5-PCP, re-
spectively. Note that there is much more PCP than 
the added d5-PCP. This was calculated to be 0.94 
Itg/ml of free PCP in the urine. 
since these gave an idea of the amount of inter-
nal standard to add or amount of sample to take 
for analysis. The method of extraction and de-
termination of PCP was adapted from Lin and 
co-workers. 8 This involves adding about 1 
JLg/ml of pentadeuterated PCP (ds-PCP) to the 
sample as the internal standard. 
The Finnigan 3200 system was used to 
monitor individual ion fragments. A 5 ft x 2 
mm glass column of 3% OV -17 of Gas Chrom 
Q was used. The oven temperature was 190° C, 
injection port 200° C, and the glass jet separator 
at 210° C to prevent excessive thermal decom-
position of PCP. In view of the fact that 91, 96, 
200, and 205 mle are the major fragments of 
PCP and ds-PCP, respectively, these ions were 
monitored and peak area ratios taken for quanti-
tation. This assay is described in detail by Wil-
son and Domino. 13 
Results 
Validation of the assay for human plasma 
and urine. Venous blood and urine from nor-
mal human volunteers were used in the initial 
studies. These subjects were free from drugs for 
at least 1 wk. Varying amounts of PCP and 1 
JLg/ml of ds-PCP were added to the plasma and 
urine samples and extracted. Approximately 
Volume 22 
Number 4 
l-p,} amounts of extract, the total volume of 
which was 20 to 25 ILl, was then injected into 
the GC-MS and a total ion chromatogram (TIC) 
obtained. In the upper portion of Fig. 1 is a 
typical TIC of normal human urine to which 
PCP and ds-PCP were added in separate sam-
ples. Note the single GC peak containing PCP 
or the ds-PCP. In the lower portion of Fig. 1 are 
the mass spectra of each. A typical mass frag-
mentogram is shown in Fig. 2. The data from 
one patient monitored over 4 days are given in 
Fig. 3, which shows the influence of urinary pH 
on the amount of PCP excreted. As urinary pH 
is decreased, PCP urine concentrations rise. 
The correlation coefficient was -0.63 with 
p < 0.004. During this period of time the pa-
tient continued to be comatose. Plasma PCP 
levels did not change markedly, as is shown in 
Table I. 
When 0.01 N HCl acid was given along with 
an intravenous infusion of fluids, as pH de-
creased the urinary excretion of PCP increased. 
Urinary pH fell and rose rapidly as a function of 
the amount of 0.01 N HCl infused. 
Upon complete recovery approximately 1 wk 
later, the patient claimed that he had taken 100 
pills which we found to contain about 5 to 6 mg 
each of PCP. The patient was in a small hospital 
for 6 days before we started to monitor urine 
and plasma. During the 3.5 days the patient was 
monitored he excreted 11.04 mg of PCP as 
such. Inasmuch as this patient claimed to have 
ingested 500 mg total of PCP, the amount ex-
creted unchanged is obviously very small. A 
portion was probably excreted during the pre-
ceding 6 days of hospitalization. However, the 
patient was still comatose. PCP could be 
sequestered in body tissues or could be primar-
ily excreted as metabolites. 14 
Table II summarizes the amount of PCP 
found in human plasma and urine from samples 
taken simultaneously in a number of studies. 
Urine PCP concentrations range from 13- to 
19-fold that of plasma. 
Discussion 
Organic bases are generally acknowledged to 
be excreted in greater amounts in an acid urine. 
The pKa of PCP as yet has not been formally 
determined under standardized conditions that 
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Fig. 3. Relationship between urinary pH and phen-
cyclidine concentration in a patient with phencyc-
lidine overdosage. Note that the lower the urinary pH 
the greater the PCP urinary concentration. During 
this period PCP plasma levels ranged from 40 to 91 
ng/ml. The patient remained unconscious and recov-
ered after approximately one week. 
Table I. Plasma PCP levels in one patient 
Time 
Day 1, IOP.M. 
Day 2, IOA.M. 
Day 3, 9 A.M. 
Day 4, 10 A.M. 
PCP (ng/ml) 
58 
91 
40 
75 
Table II. Comparison of human plasma and 
urine levels from various PCP overdose 
cases 
Reference 
49 910 Gupta et aU 
51 870 Gupta et aU 
63 863 Present 
75 267 6.5 Present 
90 850 6.4 MacLeod et al.lO 
91 090 7.4 Present 
112 1,680 4.8 Present 
116 1,430 5.5 Present 
125 1,100 Present 
190 2,750 MacLeod et al. 10 
3755 5,700 MacLeod et al.lO 
approximate those in the human organism. The 
pKa appears to be approximately 8 to 9. Am-
phetamines are perhaps the best known drugs, 
the excretion of which has clearly been shown 
to be related to urinary pH.2 Recently, Aronow 
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and Done l have reported several PCP overdose 
cases treated with urinary acidification with 
similar results. We were privileged in assaying, 
under double-blind conditions, the urine and 
blood samples of their patients. In addition, 
some of the same samples were assayed by Dr. 
D. E. Lin of Battelle, Columbus, Ohio. Our 
data were very similar and will be the subject of 
another report. 
Further studies on the treatment of PCP over-
dosage are clearly indicated. The relationship 
between pH of the urine and rate of excretion of 
the drug in the urine when plasma concen-
trations are known are the key issue rather than 
urinary pH and urinary concentration. Our lim-
ited plasma data indicate that the PCP levels did 
not change drastically over the interval the urine 
PCP levels were measured. It remains for re-
search and clinical experience to decide on the 
practicality of such a simple procedure as uri-
nary acidification in the treatment of PCP over-
dosage. Our patient showed considerable im-
provement after almost 10 days of coma. The 
role of acidification and forced diuresis in his 
recovery are not clear. Other suitable acidifying 
agents such as NH4CI should also be consid-
ered. 
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